Browse By Assay Result Page of OvirusTdb

The total number record retrieved from this search are 100. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_393Herpes simplex virusICP10PKDNAHerpesviridaeDeletion mutant with R1 domain poorly functional in HSV-1YesNoNoATCCHuman malignant melanoma cell linesA2058NANATrypan blue staining1 MOI50% cancer cell death at 48 hours after post infectionNoNoNA No responseNAInduces JNK/c-Jun, autophagy and pyroptosis activationICP10PK upregulates of caspase-1, -4, and -5, the cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-12, TNF-alpha, lymphotoxina and GM-CSF, and mitogen-activated protein kinases (MAPKs) involved in both PCD and inflammatory processesNA26602205
OV_394Herpes simplex virusICP10PKDNAHerpesviridaeDeletion mutant with R1 domain poorly functional in HSV-1NoViral strain in combination with SP600125 (100 μM)NoATCCHuman malignant melanoma cell linesA2058NANATrypan blue staining1 MOI35% cancer cell death at 48 hours after post infectionNoNoNA No responseNAInduces JNK/c-Jun, autophagy and pyroptosis activationICP10PK upregulates of caspase-1, -4, and -5, the cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-12, TNF-alpha, lymphotoxina and GM-CSF, and mitogen-activated protein kinases (MAPKs) involved in both PCD and inflammatory processesNA26602205
OV_395Herpes simplex virusICP10PKDNAHerpesviridaeDeletion mutant with R1 domain poorly functional in HSV-1NoViral strain in combination with 3-MA (5 mM)NoATCCHuman malignant melanoma cell linesA2058NANATrypan blue staining1 MOI38% cancer cell death at 48 hours after post infectionNoNoNA No responseNAInduces JNK/c-Jun, autophagy and pyroptosis activationICP10PK upregulates of caspase-1, -4, and -5, the cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-12, TNF-alpha, lymphotoxina and GM-CSF, and mitogen-activated protein kinases (MAPKs) involved in both PCD and inflammatory processesNA26602205
OV_396Herpes simplex virusICP10PKDNAHerpesviridaeDeletion mutant with R1 domain poorly functional in HSV-1NoViral strain in combination with z-YVAD- fmk (100 μM)NoATCCHuman malignant melanoma cell linesA2058NANATrypan blue staining1 MOI44% cancer cell death at 48 hours after post infectionNoNoNA No responseNAInduces JNK/c-Jun, autophagy and pyroptosis activationICP10PK upregulates of caspase-1, -4, and -5, the cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-12, TNF-alpha, lymphotoxina and GM-CSF, and mitogen-activated protein kinases (MAPKs) involved in both PCD and inflammatory processesNA26602205
OV_397Herpes simplex virusICP10PKDNAHerpesviridaeDeletion mutant with R1 domain poorly functional in HSV-1YesNoNoATCCHuman malignant melanoma cell linesA375NANATrypan blue staining1 MOI55% cancer cell death at 48 hours after post infectionNoNoNA No responseNAInduces JNK/c-Jun, autophagy and pyroptosis activationICP10PK upregulates of caspase-1, -4, and -5, the cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-12, TNF-alpha, lymphotoxina and GM-CSF, and mitogen-activated protein kinases (MAPKs) involved in both PCD and inflammatory processesNA26602205
OV_398Herpes simplex virusICP10PKDNAHerpesviridaeDeletion mutant with R1 domain poorly functional in HSV-1NoViral strain in combination with SP600125 (100 μM)NoATCCHuman malignant melanoma cell linesA375NANATrypan blue staining1 MOI35% cancer cell death at 48 hours after post infectionNoNoNA No responseNAInduces JNK/c-Jun, autophagy and pyroptosis activationICP10PK upregulates of caspase-1, -4, and -5, the cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-12, TNF-alpha, lymphotoxina and GM-CSF, and mitogen-activated protein kinases (MAPKs) involved in both PCD and inflammatory processesNA26602205
OV_399Herpes simplex virusICP10PKDNAHerpesviridaeDeletion mutant with R1 domain poorly functional in HSV-1NoViral strain in combination with 3-MA (5 mM)NoATCCHuman malignant melanoma cell linesA375NANATrypan blue staining1 MOI44% cancer cell death at 48 hours after post infectionNoNoNA No responseNAInduces JNK/c-Jun, autophagy and pyroptosis activationICP10PK upregulates of caspase-1, -4, and -5, the cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-12, TNF-alpha, lymphotoxina and GM-CSF, and mitogen-activated protein kinases (MAPKs) involved in both PCD and inflammatory processesNA26602205
OV_400Herpes simplex virusICP10PKDNAHerpesviridaeDeletion mutant with R1 domain poorly functional in HSV-1NoViral strain in combination with z-YVAD- fmk (100 μM)NoATCCHuman malignant melanoma cell linesA375NANATrypan blue staining1 MOI42% cancer cell death at 48 hours after post infectionNoNoNA No responseNAInduces JNK/c-Jun, autophagy and pyroptosis activationICP10PK upregulates of caspase-1, -4, and -5, the cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-12, TNF-alpha, lymphotoxina and GM-CSF, and mitogen-activated protein kinases (MAPKs) involved in both PCD and inflammatory processesNA26602205
OV_885Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCHepatocellular carcinoma cell lineHep3B3.0E+4 cells per wellNATrypan blue staining and hematocytometer0.1 pfu/ml75% cncer cell killing after 24 hoursNoNoNA No responseNANANANA12788648
OV_886Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCGlioblastoma cell lineU-87 MG3.0E+4 cells per wellNATrypan blue staining and hematocytometer0.1 pfu/ml85% cncer cell killing after 24 hoursNoNoNA No responseNANANANA12788648
OV_887Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCHuman prostate cancer cell lineDu1453.0E+4 cells per wellNATrypan blue staining and hematocytometer0.1 pfu/ml85% cncer cell killing after 24 hoursNoNoNA No responseNANANANA12788648
OV_888Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCHepatocellular carcinoma cell lineHep3B3.0E+4 cells per wellNATrypan blue staining and hematocytometer0.1 pfu/ml95% cncer cell killing after 48 hoursNoNoNA No responseNANANANA12788648
OV_889Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCGlioblastoma cell lineU-87 MG3.0E+4 cells per wellNATrypan blue staining and hematocytometer0.1 pfu/ml90% cncer cell killing after 48 hoursNoNoNA No responseNANANANA12788648
OV_890Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCHuman prostate cancer cell lineDu1453.0E+4 cells per wellNATrypan blue staining and hematocytometer0.1 pfu/ml95% cncer cell killing after 48 hoursNoNoNA No responseNANANANA12788648
OV_891Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCHepatocellular carcinoma cell lineHep3B3.0E+4 cells per wellNATrypan blue staining and hematocytometer0.01 pfu/ml70% cncer cell killing after 24 hoursNoNoNA No responseNANANANA12788648
OV_892Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCGlioblastoma cell lineU-87 MG3.0E+4 cells per wellNATrypan blue staining and hematocytometer0.01 pfu/ml75% cncer cell killing after 24 hoursNoNoNA No responseNANANANA12788648
OV_893Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCHuman prostate cancer cell lineDu1453.0E+4 cells per wellNATrypan blue staining and hematocytometer0.01 pfu/ml80% cncer cell killing after 24 hoursNoNoNA No responseNANANANA12788648
OV_894Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCHepatocellular carcinoma cell lineHep3B3.0E+4 cells per wellNATrypan blue staining and hematocytometer0.01 pfu/ml99% cncer cell killing after 48 hoursNoNoNA No responseNANANANA12788648
OV_895Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCGlioblastoma cell lineU-87 MG3.0E+4 cells per wellNATrypan blue staining and hematocytometer0.01 pfu/ml80% cncer cell killing after 48 hoursNoNoNA No responseNANANANA12788648
OV_896Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCHuman prostate cancer cell lineDu1453.0E+4 cells per wellNATrypan blue staining and hematocytometer0.01 pfu/ml80% cncer cell killing after 48 hoursNoNoNA No responseNANANANA12788648
OV_898Herpes simplex virusBaco-1DNAHerpesviridaeNon- fusogenic ligated with EGFP proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.01 pfu/cell2% cancer cell killing after 24 hourNoNoNA No responseNANANANA15129429
OV_899Herpes simplex virusSynco-2DNAHerpesviridaeFusogenic membrane ligated with GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.01 pfu/cell20% cancer cell killing after 24 hourNoNoNA No responseNANANANA15129429
OV_900Herpes simplex virusSynco-2DDNAHerpesviridaeDouble fusogenic expressing EGFP and GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.01 pfu/cell50% cancer cell killing after 24 hourNoNoNA No responseNANANANA15129429
OV_901Herpes simplex virusBaco-1DNAHerpesviridaeNon- fusogenic ligated with EGFP proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.01 pfu/cell20% cancer cell killing after 48 hourNoNoNA No responseNANANANA15129429
OV_902Herpes simplex virusSynco-2DNAHerpesviridaeFusogenic membrane ligated with GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.01 pfu/cell40% cancer cell killing after 48 hourNoNoNA No responseNANANANA15129429
OV_903Herpes simplex virusSynco-2DDNAHerpesviridaeDouble fusogenic expressing EGFP and GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.01 pfu/cell80% cancer cell killing after 48 hourNoNoNA No responseNANANANA15129429
OV_904Herpes simplex virusBaco-1DNAHerpesviridaeNon- fusogenic ligated with EGFP proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.01 pfu/cell60% cancer cell killing after 72 hoursNoNoNA No responseNANANANA15129429
OV_905Herpes simplex virusSynco-2DNAHerpesviridaeFusogenic membrane ligated with GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.01 pfu/cell80% cancer cell killing after 72 hoursNoNoNA No responseNANANANA15129429
OV_906Herpes simplex virusSynco-2DDNAHerpesviridaeDouble fusogenic expressing EGFP and GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.01 pfu/cell90% cancer cell killing after 72 hoursNoNoNA No responseNANANANA15129429
OV_907Herpes simplex virusBaco-1DNAHerpesviridaeNon- fusogenic ligated with EGFP proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.1 pfu/cell20% cancer cell killing after 24 hourNoNoNA No responseNANANANA15129429
OV_908Herpes simplex virusSynco-2DNAHerpesviridaeFusogenic membrane ligated with GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.1 pfu/cell30% cancer cell killing after 24 hourNoNoNA No responseNANANANA15129429
OV_909Herpes simplex virusSynco-2DDNAHerpesviridaeDouble fusogenic expressing EGFP and GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.1 pfu/cell50% cancer cell killing after 24 hourNoNoNA No responseNANANANA15129429
OV_910Herpes simplex virusBaco-1DNAHerpesviridaeNon- fusogenic ligated with EGFP proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.1 pfu/cell50% cancer cell killing after 48 hourNoNoNA No responseNANANANA15129429
OV_911Herpes simplex virusSynco-2DNAHerpesviridaeFusogenic membrane ligated with GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.1 pfu/cell60% cancer cell killing after 48 hourNoNoNA No responseNANANANA15129429
OV_912Herpes simplex virusSynco-2DDNAHerpesviridaeDouble fusogenic expressing EGFP and GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.1 pfu/cell100% cancer cell killing after 48 hourNoNoNA No responseNANANANA15129429
OV_913Herpes simplex virusBaco-1DNAHerpesviridaeNon- fusogenic ligated with EGFP proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.1 pfu/cell60% cancer cell killing after 72 hoursNoNoNA No responseNANANANA15129429
OV_914Herpes simplex virusSynco-2DNAHerpesviridaeFusogenic membrane ligated with GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.1 pfu/cell80% cancer cell killing after 72 hoursNoNoNA No responseNANANANA15129429
OV_915Herpes simplex virusSynco-2DDNAHerpesviridaeDouble fusogenic expressing EGFP and GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.1 pfu/cell100% cancer cell killing after 72 hoursNoNoNA No responseNANANANA15129429
OV_1162Herpes simplex virusFusOn-H2 strainDNAHerpesviridaeDouble fusogenic expressing EGFP and GALV.fus proteinYesNoNoATCCRenal cell carcinoma cell lineACHN1.5E+3 cells per wellNATrypan blue staining0.1 pfu/cell50% cell survival after 24 hoursNoNoNA No responseNANANANA17487379
OV_1163Herpes simplex virusBaco-1DNAHerpesviridaeNon- fusogenic ligated with EGFP proteinYesNoNoATCCRenal cell carcinoma cell lineA4891.5E+3 cells per wellNATrypan blue staining0.1 pfu/cell55% cell survival after 24 hoursNoNoNA No responseNANANANA17487379
OV_1164Herpes simplex virusFusOn-H2 strainDNAHerpesviridaeDouble fusogenic expressing EGFP and GALV.fus proteinYesNoNoATCCRenal cell carcinoma cell lineACHN1.5E+3 cells per wellNATrypan blue staining0.1 pfu/cell5% cell survival after 48 hoursNoNoNA No responseNANANANA17487379
OV_1165Herpes simplex virusBaco-1DNAHerpesviridaeNon- fusogenic ligated with EGFP proteinYesNoNoATCCRenal cell carcinoma cell lineA4891.5E+3 cells per wellNATrypan blue staining0.1 pfu/cell20% cell survival after 48 hoursNoNoNA No responseNANANANA17487379
OV_1166Herpes simplex virusFusOn-H2 strainDNAHerpesviridaeDouble fusogenic expressing EGFP and GALV.fus proteinYesNoNoATCCRenal cell carcinoma cell lineACHN1.5E+3 cells per wellNATrypan blue staining0.01pfu/cell55% cell survival after 24 hoursNoNoNA No responseNANANANA17487379
OV_1167Herpes simplex virusBaco-1DNAHerpesviridaeNon- fusogenic ligated with EGFP proteinYesNoNoATCCRenal cell carcinoma cell lineA4891.5E+3 cells per wellNATrypan blue staining0.01pfu/cell57% cell survival after 24 hoursNoNoNA No responseNANANANA17487379
OV_1168Herpes simplex virusFusOn-H2 strainDNAHerpesviridaeDouble fusogenic expressing EGFP and GALV.fus proteinYesNoNoATCCRenal cell carcinoma cell lineACHN1.5E+3 cells per wellNATrypan blue staining0.01pfu/cell10% cell survival after 48 hoursNoNoNA No responseNANANANA17487379
OV_1169Herpes simplex virusBaco-1DNAHerpesviridaeNon- fusogenic ligated with EGFP proteinYesNoNoATCCRenal cell carcinoma cell lineA4891.5E+3 cells per wellNATrypan blue staining0.01pfu/cell30% cell survival after 48 hoursNoNoNA No responseNANANANA17487379
OV_1264Herpes simplex virusHSV-HF10DNAHerpesviridaeAttenuated strain of HSVYesNoNoTohuku University, JapanMurine melanoma cell lineM32.0E+5 cells per wellNATrypan Blue exclusion assay3 MOI20% cell viablity observed after 24 hoursNoNoNA No responseNANANANA18226503
OV_1265Herpes simplex virusHSV-HF10DNAHerpesviridaeAttenuated strain of HSVYesNoNoTohuku University, JapanMurine melanoma cell lineM32.0E+5 cells per wellNATrypan Blue exclusion assay0.3 MOI25% cell viablity after 24 hoursNoNoNA No responseNANANANA18226503
OV_1266Herpes simplex virusHSV-HF10DNAHerpesviridaeAttenuated strain of HSVYesNoNoTohuku University, JapanMurine melanoma cell lineM32.0E+5 cells per wellNATrypan Blue exclusion assay0.03 MOI40% cell viablity after 24 hoursNoNoNA No responseNANANANA18226503
OV_1267Herpes simplex virusHSV-HF10DNAHerpesviridaeAttenuated strain of HSVYesNoNoTohuku University, JapanMurine melanoma cell lineM32.0E+5 cells per wellNATrypan Blue exclusion assay0.003 MOI90% cell viability after 24 hoursNoNoNA No responseNANANANA18226503
OV_1268Herpes simplex virusHSV-HF10DNAHerpesviridaeAttenuated strain of HSVYesNoNoTohuku University, JapanMurine melanoma cell lineM32.0E+5 cells per wellNATrypan Blue exclusion assay3 MOINo cell viability after 48 hoursNoNoNA No responseNANANANA18226503
OV_1269Herpes simplex virusHSV-HF10DNAHerpesviridaeAttenuated strain of HSVYesNoNoTohuku University, JapanMurine melanoma cell lineM32.0E+5 cells per wellNATrypan Blue exclusion assay0.3 MOINo cell viability after 48 hoursNoNoNA No responseNANANANA18226503
OV_1270Herpes simplex virusHSV-HF10DNAHerpesviridaeAttenuated strain of HSVYesNoNoTohuku University, JapanMurine melanoma cell lineM32.0E+5 cells per wellNATrypan Blue exclusion assay0.03 MOI10% cell viabilty after 48 hoursNoNoNA No responseNANANANA18226503
OV_1271Herpes simplex virusHSV-HF10DNAHerpesviridaeAttenuated strain of HSVYesNoNoTohuku University, JapanMurine melanoma cell lineM32.0E+5 cells per wellNATrypan Blue exclusion assay0.003 MOI40% cell viability after 48 hoursNoNoNA No responseNANANANA18226503
OV_1272Herpes simplex virusHSV-HF10DNAHerpesviridaeAttenuated strain of HSVYesNoNoTohuku University, JapanMurine melanoma cell lineM32.0E+5 cells per wellNATrypan Blue exclusion assay3 MOINo cell viability after 72 hoursNoNoNA No responseNANANANA18226503
OV_1273Herpes simplex virusHSV-HF10DNAHerpesviridaeAttenuated strain of HSVYesNoNoTohuku University, JapanMurine melanoma cell lineM32.0E+5 cells per wellNATrypan Blue exclusion assay0.3 MOINo cell viability after 72 hoursNoNoNA No responseNANANANA18226503
OV_1274Herpes simplex virusHSV-HF10DNAHerpesviridaeAttenuated strain of HSVYesNoNoTohuku University, JapanMurine melanoma cell lineM32.0E+5 cells per wellNATrypan Blue exclusion assay0.03 MOINo cell viability after 72 hoursNoNoNA No responseNANANANA18226503
OV_1275Herpes simplex virusHSV-HF10DNAHerpesviridaeAttenuated strain of HSVYesNoNoTohuku University, JapanMurine melanoma cell lineM32.0E+5 cells per wellNATrypan Blue exclusion assay0.003 MOI7.4% cell viability after 72 hoursNoNoNA No responseNANANANA18226503
OV_3045Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman cervical cancer cell lineHeLa3.0E+5 cells per wellNATrypan blue assay10⁻⁴ MOI30% cell viabilityNoNoNA No responseNANANANA31011628
OV_3046Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman cervical cancer cell lineHeLa3.0E+5 cells per wellNATrypan blue assay10⁻³ MOI100% cell deathNoNoNA No responseNANANANA31011628
OV_3047Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman cervical cancer cell lineHeLa3.0E+5 cells per wellNATrypan blue assay10⁻² MOI100% cell deathNoNoNA No responseNANANANA31011628
OV_3048Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman colon cancer cell lineLoVo3.0E+5 cells per wellNATrypan blue assay10⁻⁴ MOI100% cell viabilityNoNoNA No responseNANANANA31011628
OV_3049Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman colon cancer cell lineLoVo3.0E+5 cells per wellNATrypan blue assay10⁻³ MOI70% cell viabilityNoNoNA No responseNANANANA31011628
OV_3050Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman colon cancer cell lineLoVo3.0E+5 cells per wellNATrypan blue assay10⁻² MOI15% cell viabilityNoNoNA No responseNANANANA31011628
OV_3051Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman lung cancer cell lineA5493.0E+5 cells per wellNATrypan blue assay10⁻⁴ MOI18% cell viabilityNoNoNA No responseNANANANA31011628
OV_3052Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman lung cancer cell lineA5493.0E+5 cells per wellNATrypan blue assay10⁻³ MOI10% cell viabilityNoNoNA No responseNANANANA31011628
OV_3053Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman lung cancer cell lineA5493.0E+5 cells per wellNATrypan blue assay10⁻² MOI1% cell viabilityNoNoNA No responseNANANANA31011628
OV_3054Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman glioblastoma cell lineU-87 MG3.0E+5 cells per wellNATrypan blue assay10⁻⁴ MOI30% cell viabilityNoNoNA No responseNANANANA31011628
OV_3055Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman glioblastoma cell lineU-87 MG3.0E+5 cells per wellNATrypan blue assay10⁻³ MOI10% cell viabilityNoNoNA No responseNANANANA31011628
OV_3056Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman glioblastoma cell lineU-87 MG3.0E+5 cells per wellNATrypan blue assay10⁻² MOI1% cell viabilityNoNoNA No responseNANANANA31011628
OV_3057Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman hepatocellular carcinoma cell lineHepG23.0E+5 cells per wellNATrypan blue assay10⁻⁴ MOI18% cell viabilityNoNoNA No responseNANANANA31011628
OV_3058Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman hepatocellular carcinoma cell lineHepG23.0E+5 cells per wellNATrypan blue assay10⁻³ MOI1% cell viabilityNoNoNA No responseNANANANA31011628
OV_3059Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman hepatocellular carcinoma cell lineHepG23.0E+5 cells per wellNATrypan blue assay10⁻² MOI100% cell deathNoNoNA No responseNANANANA31011628
OV_3060Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman bladder cancer cell lineSW7803.0E+5 cells per wellNATrypan blue assay10⁻⁴ MOI50% cell viabilityNoNoNA No responseNANANANA31011628
OV_3061Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman bladder cancer cell lineSW7803.0E+5 cells per wellNATrypan blue assay10⁻³ MOI10% cell viabilityNoNoNA No responseNANANANA31011628
OV_3062Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman bladder cancer cell lineSW7803.0E+5 cells per wellNATrypan blue assay10⁻² MOI100% cell deathNoNoNA No responseNANANANA31011628
OV_3063Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoECACCHuman eosophageal cancer cell lineOE193.0E+5 cells per wellNATrypan blue assay10⁻⁴ MOI80% cell viabilityNoNoNA No responseNANANANA31011628
OV_3064Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoECACCHuman eosophageal cancer cell lineOE193.0E+5 cells per wellNATrypan blue assay10⁻³ MOI50% cell viabilityNoNoNA No responseNANANANA31011628
OV_3065Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoECACCHuman eosophageal cancer cell lineOE193.0E+5 cells per wellNATrypan blue assay10⁻² MOI10% cell viabilityNoNoNA No responseNANANANA31011628
OV_3066Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoCantren Antoine- lacassagne, FranceHuman head and neck squamous cell carcinoma cell lineCAL333.0E+5 cells per wellNATrypan blue assay10⁻⁴ MOI18% cell viabilityNoNoNA No responseNANANANA31011628
OV_3067Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoCantren Antoine- lacassagne, FranceHuman head and neck squamous cell carcinoma cell lineCAL333.0E+5 cells per wellNATrypan blue assay10⁻³ MOI1% cell viabilityNoNoNA No responseNANANANA31011628
OV_3068Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoCantren Antoine- lacassagne, FranceHuman head and neck squamous cell carcinoma cell lineCAL333.0E+5 cells per wellNATrypan blue assay10⁻² MOI100% cell deathNoNoNA No responseNANANANA31011628
OV_3069Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman stomach cancer cell lineHs746T3.0E+5 cells per wellNATrypan blue assay10⁻⁴ MOI18% cell viabilityNoNoNA No responseNANANANA31011628
OV_3070Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman stomach cancer cell lineHs746T3.0E+5 cells per wellNATrypan blue assay10⁻³ MOI1% cell viabilityNoNoNA No responseNANANANA31011628
OV_3071Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman stomach cancer cell lineHs746T3.0E+5 cells per wellNATrypan blue assay10⁻² MOI100% cell deathNoNoNA No responseNANANANA31011628
OV_3072Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman colon cancer cell lineHCT-1163.0E+5 cells per wellNATrypan blue assay10⁻⁴ MOI30% cell viabilityNoNoNA No responseNANANANA31011628
OV_3073Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman colon cancer cell lineHCT-1163.0E+5 cells per wellNATrypan blue assay10⁻³ MOI5% cell viabilityNoNoNA No responseNANANANA31011628
OV_3074Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman colon cancer cell lineHCT-1163.0E+5 cells per wellNATrypan blue assay10⁻² MOI1% cell viabilityNoNoNA No responseNANANANA31011628
OV_3075Vaccinia virusDeltaJ2R-I4L/FCU1 VACV (TG6002)DNAPoxviridaeDeletion of J2R and I4L gene and insertion of gene FCU1YesNoNoATCCHuman cervical cancer cell lineHeLa3.0E+5 cells per wellNATrypan blue assay10⁻⁴ MOI18% cell viabilityNoNoNA No responseNANANANA31011628
OV_3076Vaccinia virusDeltaJ2R-I4L/FCU1 VACV (TG6002)DNAPoxviridaeDeletion of J2R and I4L gene and insertion of gene FCU1YesNoNoATCCHuman cervical cancer cell lineHeLa3.0E+5 cells per wellNATrypan blue assay10⁻³ MOI1% cell viabilityNoNoNA No responseNANANANA31011628
OV_3077Vaccinia virusDeltaJ2R-I4L/FCU1 VACV (TG6002)DNAPoxviridaeDeletion of J2R and I4L gene and insertion of gene FCU1YesNoNoATCCHuman cervical cancer cell lineHeLa3.0E+5 cells per wellNATrypan blue assay10⁻² MOI1% cell viabilityNoNoNA No responseNANANANA31011628
OV_3078Vaccinia virusDeltaJ2R-I4L/FCU1 VACV (TG6002)DNAPoxviridaeDeletion of J2R and I4L gene and insertion of gene FCU1YesNoNoATCCHuman colon cancer cell lineLoVo3.0E+5 cells per wellNATrypan blue assay10⁻⁴ MOI100% cell viabilityNoNoNA No responseNANANANA31011628
OV_3079Vaccinia virusDeltaJ2R-I4L/FCU1 VACV (TG6002)DNAPoxviridaeDeletion of J2R and I4L gene and insertion of gene FCU1YesNoNoATCCHuman colon cancer cell lineLoVo3.0E+5 cells per wellNATrypan blue assay10⁻³ MOI70% cell viabilityNoNoNA No responseNANANANA31011628
OV_3080Vaccinia virusDeltaJ2R-I4L/FCU1 VACV (TG6002)DNAPoxviridaeDeletion of J2R and I4L gene and insertion of gene FCU1YesNoNoATCCHuman colon cancer cell lineLoVo3.0E+5 cells per wellNATrypan blue assay10⁻² MOI15% cell viabilityNoNoNA No responseNANANANA31011628
OV_3081Vaccinia virusDeltaJ2R-I4L/FCU1 VACV (TG6002)DNAPoxviridaeDeletion of J2R and I4L gene and insertion of gene FCU1YesNoNoATCCHuman lung cancer cell lineA5493.0E+5 cells per wellNATrypan blue assay10⁻⁴ MOI30% cell viabilityNoNoNA No responseNANANANA31011628
OV_3082Vaccinia virusDeltaJ2R-I4L/FCU1 VACV (TG6002)DNAPoxviridaeDeletion of J2R and I4L gene and insertion of gene FCU1YesNoNoATCCHuman lung cancer cell lineA5493.0E+5 cells per wellNATrypan blue assay10⁻³ MOI15% cell viabilityNoNoNA No responseNANANANA31011628
OV_3083Vaccinia virusDeltaJ2R-I4L/FCU1 VACV (TG6002)DNAPoxviridaeDeletion of J2R and I4L gene and insertion of gene FCU1YesNoNoATCCHuman lung cancer cell lineA5493.0E+5 cells per wellNATrypan blue assay10⁻² MOI5% cell viabilityNoNoNA No responseNANANANA31011628
OV_3084Vaccinia virusDeltaJ2R-I4L/FCU1 VACV (TG6002)DNAPoxviridaeDeletion of J2R and I4L gene and insertion of gene FCU1YesNoNoATCCHuman glioblastoma cell lineU-87 MG3.0E+5 cells per wellNATrypan blue assay10⁻⁴ MOI30% cell viabilityNoNoNA No responseNANANANA31011628
OV_3085Vaccinia virusDeltaJ2R-I4L/FCU1 VACV (TG6002)DNAPoxviridaeDeletion of J2R and I4L gene and insertion of gene FCU1YesNoNoATCCHuman glioblastoma cell lineU-87 MG3.0E+5 cells per wellNATrypan blue assay10⁻³ MOI15% cell viabilityNoNoNA No responseNANANANA31011628
OV_3086Vaccinia virusDeltaJ2R-I4L/FCU1 VACV (TG6002)DNAPoxviridaeDeletion of J2R and I4L gene and insertion of gene FCU1YesNoNoATCCHuman glioblastoma cell lineU-87 MG3.0E+5 cells per wellNATrypan blue assay10⁻² MOI5% cell viabilityNoNoNA No responseNANANANA31011628